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ABSTRACT
Survival time-associated plant homeodomain (PHD)
finger protein in Ovarian Cancer 1 (SPOC1, also
known as PHF13) is known to modulate chromatin
structure and is essential for testicular stem-cell dif-
ferentiation. Herewe show that SPOC1 is recruited to
DNA double-strand breaks (DSBs) in an ATM-
dependent manner. Moreover, SPOC1 localizes at
endogenous repair foci, including OPT domains and
accumulates at large DSB repair foci characteristic
for delayed repair at heterochromatic sites.
SPOC1 depletion enhances the kinetics of ionizing
radiation-induced foci (IRIF) formation after
c-irradiation (c-IR), non-homologous end-joining
(NHEJ) repair activity, and cellular radioresistance,
but impairs homologous recombination (HR) repair.
Conversely, SPOC1 overexpression delays IRIF for-
mation and cH2AX expansion, reduces NHEJ repair
activity and enhances cellular radiosensitivity.
SPOC1 mediates dose-dependent changes in chro-
matin association of DNA compaction factors KAP-1,
HP1-a and H3K9 methyltransferases (KMT) GLP,
G9A and SETDB1. In addition, SPOC1 interacts
with KAP-1 and H3K9 KMTs, inhibits KAP-1 phos-
phorylation and enhances H3K9 trimethylation.
These findings provide the first evidence for a
function of SPOC1 in DNA damage response (DDR)
and repair. SPOC1 acts as a modulator of repair
kinetics and choice of pathways. This involves its
dose-dependent effects on DNA damage sensors,
repair mediators and key regulators of chromatin
structure.
INTRODUCTION
Elevated SPOC1 RNA levels of the human SPOC1 gene
are associated with unresectable carcinomas and shorter
survival in ovarian cancer patients, implicating a possible
role in oncogenesis (1). The SPOC1 protein was recently
also demonstrated to function in chromatin condensation
and decondensation (2). The ability of SPOC1 to associate
with, and structurally alter chromatin depends on its plant
homeodomain (PHD) (2), predicted to bind to H3K4me2/
3 (3). In a mouse SPOC1 knockout model, SPOC1 protein
expression was also recently shown to be indispensable for
testis stem-cell differentiation and sustained spermatogen-
esis (4). These ﬁndings imply that SPOC1 plays a role in
stem-cell maintenance, chromatin structure, and presum-
ably also in oncogenesis. Considering these data and pub-
lished evidence that chromatin structure plays a crucial
role in radiosensitivity, DNA repair and mutation rates
in cancer cells (5), we wanted to examine whether
SPOC1 also has an impact on DNA damage response
(DDR) and DNA repair.
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Upon DNA damage, cells undergo a coordinated
cascade of events which can result in DNA repair,
which preserves genome stability and is critical in prevent-
ing tumorigenesis (6). DNA damage activates the DDR,
which in turn induces cell-cycle arrest, and ensuing DNA
repair or apoptosis. DDR proteins are hierarchically re-
cruited to DNA damage sites and can be visualized as
repair foci. In response to double-strand breaks (DSBs),
the histone variant H2AX is phosphorylated (gH2AX) by
the ATM kinase, which then associates with the MRN
complex, triggering further chromatin alterations and
the focal recruitment of additional DDR mediators,
including 53BP1 (7). gH2AX and 53BP1 play distinct
roles in DDR initiation and DNA repair of heterochro-
matin (8,9).
Two main DDR pathways drive repair of DSBs: hom-
ologous recombination (HR) and non-homologous
end-joining (NHEJ) (10–12). HR requires a sister chroma-
tid and can precisely repair DSBs primarily in the S phase
of the cell cycle (13). In contrast, NHEJ functions
throughout the cell cycle and is the main repair pathway
for cells in G1 and G2. Since NHEJ does not require a
homologous template and is error prone, it is potentially
mutagenic (14).
Repair of DNA damage in euchromatin and hetero-
chromatin are divergent due to different accessibility and
requirements for DDR proteins. Approximately 10–25%
of nuclear DNA is heterochromatic and characterized by
H3K9me2/3 epigenetic marks (15,16). Recruitment of
corepressors such as KAP-1 and the H3K9 KMTs
(SUV39H1, SETDB1, G9A and GLP) to chromatin
promotes its compaction by increasing histone H3K9 di
and trimethylation, thereby potentiating the binding of
chromodomain (CD) containing condensing ‘mediators’
such as HP1 (17,18).
In the event of DNA damage, the DNA repair machin-
ery must overcome the physical barrier of heterochroma-
tin (19–22). To achieve this, histones and chromatin-
afﬁliated proteins are speciﬁcally post-translationally
modiﬁed; then ATP-dependent chromatin remodeling
factors are engaged to unwind the chromatin locally and
facilitate access to the damaged DNA (6,23). For instance,
regulation of H3K9me3 levels by several KMTs is intim-
ately linked to the activation of ATM via TIP60-mediated
acetylation at DSBs, a key process in coordinating DNA
repair pathways (24). ATM helps locally to overcome the
barrier to DDR signaling posed by heterochromatin by
enhancing gH2AX expansion at repair foci, as shown
with cells deﬁcient in several heterochromatin components
(25). This study also showed that heterochromatin has a
substantial impact on the magnitude of ATM signaling
and contributes to an inefﬁcient G2/M checkpoint
response.
Modulation of chromatin structure is a fundamental
feature of DDR and DNA repair pathways (21,22). The
heterochromatin building factors, KAP-1 and HP1, which
are linked to H3K9 methylation, are important for, and
affected by the DDR (26–28). After g-IR, KAP-1 is
phosphorylated at Ser824 by ATM, promoting chromatin
decondensation at repair sites and enhancing cellular
survival (29). It was previously demonstrated that
phosphorylated KAP-1 (pKAP-1) is essential for repairing
heterochromatin DSBs (9,30). Likewise, HP1 proteins are
also phosphorylated in response to DNA damage, and
appear important for recruiting DDR factors and dynam-
ically reorganizing chromatin (27,31). Recently, HP1-a
was shown to regulate KAP-1’s phosphorylation and ac-
cumulation at repair foci (32), linking both proteins to
chromatin structural changes during DNA repair in
heterochromatin.
Here we show that SPOC1 modulates DDR, NHEJ and
HR repair pathways, and inﬂuences the radiosensitivity of
cells by alternating key determinants of chromatin struc-
ture and interacting with DDR modiﬁers. Thus our data
identify SPOC1 as a novel player in DDR and argue for its
involvement in cancer development.
MATERIALS AND METHODS
Cell lines
U2OS, U2OS DR-GFP, U2OS19 ptight13 GFP-LacR,
HEK293, CV1 cells, HeLa-S3 and C2C12 myoblasts
were cultured according to the supplier’s instructions or
as described previously (33–35).
SPOC1 inducible CV1 cell lines were generated with the
Tet-On system (Invitrogen) by cotransfecting pcDNA6/
TR Tet-repressor and pcDNA-4TO-FLAG-SPOC1-
expression plasmids. Cells were selected with 300 mg/ml
zeocin and 1.8mg/ml blasticidine (Invivogen) before
isolating single colonies. FLAG-SPOC1 expression was
induced with 1 mg/ml doxycycline (Dox, Sigma). All cells
were g-irradiated with 2Gy, unless indicated otherwise,
using a 137Cs source.
Polyclonal HeLa-S3 cell lines stably expressing either
FLAG-HA-tagged SETDB1 or pREV control vector
(33) were analyzed before and after superinfection with
lentiviruses (LeGO-iG2) expressing human SPOC1 wt or
a PHD domain mutant (M246A+W255A). Detailed
protocols for LeGO vector production and titration are
reported elsewhere (36).
Plasmids
Expression constructs for human SPOC1, SPOC1
mutants lacking amino acids 21–70 (deltaN), mutated in
the PHD domain (M246A+W255A), or N-terminally
FLAG-tagged SPOC1 constructs were generated in the
pcDNA4-TO vector (Invitrogen). GST-fusion proteins
for human SPOC1 full–length fragments, and deletion de-
rivatives were produced with vector pGEX4T3
(GE Healthcare) in Escherichia coli. For the LUMIER
assay, cDNAs for human SPOC1 and KAP-1 full-length
and fragments were subcloned into pTREX-dest30nt-PrA
(N-terminal protein A tag fusion) and/or pcDNA3-RL
GW (N-terminal renilla luciferase fusion), provided by
M. Koegel, DKFZ, Heidelberg.
siRNA-mediated knockdown
CV1 cells were transfected with 100 nM SPOC1-speciﬁc
siRNA (50-UCACCUGUCCUGUGCGAAA-30) or
control siRNA (50-AGGUAGUGUAAUCGCCUUG-30)
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as described before (2) using Rotifect plus (Roth) and
subsequently g-irradiated.
Drug treatments
Cells were treated with 100 ng/ml neocarzinostatin (NCS)
(Sigma) for 15min and afterwards cells were washed 2
with PBS and ﬁxed at indicated time points. ATM inhibitor
(KU55933) (37) (Tocris) was used at 20 mM.
Antibodies
Indirect immunoﬂuroescence and immunoblotting
were performed using antibodies to gH2AX (05-636;
Millipore), 53BP1 (NB100-304; Novus), b-actin (A-5441;
Sigma), ATM (1549-1, Epitomics), pATM-S1981 (2152-1;
Epitomics), Chk2 (sc-56297; Santa Cruz), pChk2-T68
(2661; Cell signaling), CtIP (D4) (sc-271339; Sigma),
FLAG (F1804; Sigma), G9A (D141-3; Clinisciences),
G9A (A300-933A; Bethyl), GAPDH (sc-32233; Santa
Cruz), GLP (PP-B0422-00; R&D Systems), GLP
(Bethyl; A301-642A), H3 (1326-1; Epitomics), H3K9me3
(07-442; Upstate), HP1-a (05-689; Upstate), HP1-b
(ab10811; Abcam), HP1-g (ab10817; Abcam), Tif1-b/
KAP-1 (MAB3662; Millipore), pKAP-1-S824 (A300-
767A-1; Bethyl), SETDB1 (ab12317; Abcam), SETDB1
(A300-121A; Bethyl), SUV39H1 (05-615; Upstate),
SUV39H1 (07-550; Upstate). SPOC1 was detected with
6F6 rat monoclonal antibody (2) unless stated otherwise.
Rabbit polyclonal anti-SPOC1 (CR56) was raised against
amino acids 286–300 of human SPOC1 and rat monoclo-
nal anti-SPOC1 (1D3) was raised against human SPOC1
fused to GST.
Proliferation assay
CV1 cells and three different FLAG-SPOC1 (#14, #17,
#23) expressing cell lines were seeded at a concentration
of 2 105 cells per 6-cm dish at Day 0. FLAG-SPOC1
cells were induced with Dox (1 mg/ml) or treated with
ethanol on Day 0, which was replenished every 3 days.
The cells were counted every 2–3 days in triplicates and
cultivated over a period of 9 days.
Extraction protocol, immunoblotting and
immunoprecipitation
SPOC1 protein was extracted from cell pellets using either
(i) a sodium dodecyl sulfate (SDS) total-cell lysate extrac-
tion buffer (50mM Tris, pH 6.8, 2% SDS and 10%
glycerol) or (ii) a fractionated lysate protocol. (i) In
brief, the cell pellet (1 107 cells) was resuspended in
100 ml of SDS total-cell lysis buffer supplemented with
1 protease inhibitor cocktail (EDTA-free complete,
Roche), 1mM NaF (Sigma), 1mM NaVO3 (Sigma) and
1mM PMSF (Calbiochem), heated at 99C for 5min, sup-
plemented with Laemmli buffer and then reheated for an
additional 5min at 99C before loading on a SDS–PAGE.
(ii) The fractionated lysate protocol was performed as fol-
lows: soluble cellular proteins from 1 107 cells were
extracted with 100 ml of E1A buffer [150mM
NaCl, 50mM HEPES, 0.1% NP-40 supplemented with
5mM NaF, 5 mg/ml Trasylol (Aprotinin), 250mg/ml
Pefablock SC, 1mM NaVO3, 1 PhosSTOP (Roche)
and 1 complete (EDTA-free, Roche)] for 25min on ice
and were then centrifuged (15min, 16 100g, 4C).
Chromatin-associated proteins were extracted from the
remaining pellet in 100 ml of a chromatin extraction
buffer [0.4M NaCl, 50mM HEPES, 1% Triton X-100,
0.1% NP-40, 2.5mM MgCl2, 25U of Benzonase
(Novagen)] supplemented with 5mM NaF, 5 mg/
ml Trasylol (Aprotinin), 250 mg/ml Pefablock SC,
1mM NaVO3, 1 PhosSTOP (Roche) and 1 complete
(EDTA-free, Roche) for 25min on ice and were then
centrifuged (15min, 16 100g, 4C). SDS–polyacrylamide
gel electrophoresis (PAGE) and immunoblotting were per-
formed using standard protocols. Immunoblot signals
were quantiﬁed by densitometry using ImageQuant
LAS4000 and the ImageQuant TL Software or by using
the ImageJ Software. Nuclear extracts used for
immunoprecipitation of H3K9 KMTase complexes
shown in Supplementary Figure S6 were prepared as
described above, except that before use, we added Turbo
DNase buffer and preheated for 1min at 37C before
treating with 1.7KU/ml Turbo DNase I (Ambion) for
20min at 37C (repeated twice). Finally we incubated
the nuclear extract with 0.06mg/ml RNase (Sigma) for
15min on ice. Alternatively, the extract were preheated
the samples for 1min at 37C in the presence of 1mM
CaCl2 and then treated with 0.0125U/ml MNase at 37C
for 15min. With 4mM EDTA the MNase digestion was
stopped and the extract incubated with or without 1%
ethidium bromide (Etbr) on ice before use. Nuclear
extracts were subjected to either G9A complex puriﬁca-
tion or used for immunoprecipitation of the endogenous
SPOC1 protein, essentially as described (33).
Immunoﬂuorescence and ionizing radiation-induced
foci quantiﬁcation
Cell lines were ﬁxed and immunostained as described
before (2). In g-irradiated cells the number of ionizing
radiation-induced foci (IRIF) per cell was determined by
automated high-content imaging (700–1000 cells/
timepoint, BD Pathway 855 Bioimager) using the BD
AttoVision-Software v1.6.
DNA DSB repair reporter assay
H1299.EJ, H1299.GC and U2OS DR-GFP reporter cells
were used to measure NHEJ and HR repair as described
(35,38–41). For SPOC1 depletion, cells were cotransfected
with 100 nM control or SPOC1-speciﬁc siRNA and
2 mg pDsRed-I-SceI-GR. For SPOC1 overexpression,
1 mg of pcDNA4/TO-SPOC1, SPOC1 M246A/W255A or
SPOC1NTD expression plasmid was cotransfected with
1 mg pDsRed-I-SceI-GR. 24 h after transfection, I-SceI
site-speciﬁc DSBs were induced by addition of 100 ng/ml
triamcinolone acetonide (TA, Sigma) and cells were har-
vested 24 h (NHEJ) or 48 h (HR) thereafter. The number
of DNA repair indicating GFP positive cells were
determined by FACS (FACScan, BD Biosiences) and
normalized to the fraction of pDsRed-I-SceI-GR
positive cells. For additional controls performed see
Supplementary Information.
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Comet assay
The Comet assay was performed as described previously
(42). SPOC1 knockdown cells and two different FLAG-
SPOC1 (#17, #23) expressing cell lines were irradiated
with 2Gy on ice and harvested immediately. The olive
tail moment was measured with the Comet analysis
software VisComet 4.0 (Impuls Bildanalyse GmbH).
Sixty comets were scored for each treated sample.
LUMIER assay
The LUMIER assay was performed as described (43).
In brief, the indicated KAP-1 and SPOC1 sequences
fused to either protein A or luciferase were expressed in
HEK293 cells. Protein A fusion proteins were puriﬁed
from cell lysates, mixed with sheep anti-rabbit IgG-
coated magnetic beads (Dynabeads M280, Invitrogen).
Luciferase activity of copuriﬁed luciferase-tagged
proteins was measured in four lysates and the correspond-
ing washed beads. Lysates from cells expressing the
luciferase fusion protein and a protein A dimer served as
negative controls (nc). Normalized interaction signals
were calculated Log(bound)/log(input) log(bound nc)/
log(input nc) and z-transformed by subtracting the mean
and dividing by the standard deviation. The mean and
standard deviation were calculated from large data sets
of protein pairs not expected to interact. Normalized
signal to noise ratios were calculated as (bound/input)/
(bound nc/input nc) (44).
GST pull-down
U2OS cells were lysed for 10min with buffer 1 [150mM
NaCl, 25mM HEPES, 2.5mM MgCl2, 10% glycerol,
0.1% NP-40, 5mM NaF, 250 mg/ml Pefablock SC,
1mM NaVO3 and 1 protease inhibitor cocktail
(Roche)] and centrifuged at 16 000g at 4C for 10min.
The supernatant was discarded and pellets were lysed for
30min in ice-cold buffer 2 (150mM NaCl, 25mM
HEPES, 2.5mM MgCl2, 10% glycerol, 0.1% NP-40,
250mg/ml Pefablock SC and 1 Complete)+25–50
units benzonase (Novagen) and cleared by centrifugation
at 16 000g at 4C for 10min. Cell lysates were incubated
with recombinant GST-fusion proteins produced in E. coli
and bound to glutathione-S-transferase beads for 1–2 h at
4C under rotation. Beads were washed three times with
PBS and bound proteins were analyzed by SDS–PAGE
and immunoblotting.
Histone methylation assay
Histone methylation assay was monitored as previously
described (33). Brieﬂy, immunoprecipitated material was
incubated with 5 mg of core histones (ref. 13-107, Upstate)
and 1.5mCi of Adenosyl-L-Methionine, S-[methyl-3H] (ref.
NET155050UC, PerkinElmer) in a buffer containing
50mM Tris pH 8.0, 100mM NaCl, 1% NP40, 1mM
DTT and protease inhibitors (reaction volume 30 ml).
The mixture was incubated 1 h at 30C followed by
SDS–PAGE analysis. The gel was stained by SimplyBlue
kit (Invitrogen), and analyzed by autoradiography. IP
efﬁciency was monitored by immunoblot (IB).
Clonogenic survival assays
CV1 cells transfected with control or SPOC1-speciﬁc
siRNA for 24 h and uninduced CV1 FLAG-SPOC1 cell
lines were g-irradiated with 0, 2, 4, 6 and 8Gy. Cells were
plated at different concentrations (125–1000 cells/6-cm
plate) in triplicate and grown for 9–12 days. Colonies
were ﬁxed with methanol, stained with Giemsa (Merck)
and counted.
Statistical tests
Data signiﬁcance was determined using an unpaired two
tailed Student’s t-test.
RESULTS
SPOC1 is recruited to DSBs
To determine whether SPOC1 is speciﬁcally recruited to
DSBs, we used the reporter cell line U2OS19 ptight13
GFPlacR, which carries a stably integrated lac-operator
array upstream of a I-SceI restriction site followed down-
stream by an array of Dox response elements (34). In
addition, this cell line contains two transgenes, one consti-
tutively expressing GFP-LacR, and the other expressing
Dox-inducible HA-I-SceI endonuclease in most cells, but
due to leaky expression also Dox-independently in a few
cells. The I-SceI site is converted into DSBs in most cells
after Dox-induced I-SceI endonuclease expression. The
GFP-LacR protein binds to lac-operator sequences,
forming a single green dot independently of I-SceI restric-
tion site cleavage by the endonuclease (45) (Figure 1A). In
these non-treated cells endogenous SPOC1 protein was
concentrated at many, but not all endogenous 53BP1-
positive repair foci (Figure 1A). Prior to Dox-induced
I-SceI expression, SPOC1 did not accumulate at GFP-
LacR stained LacO arrays devoid of focal 53BP1 staining
(Figure 1A, -I-SceI-). In contrast, 16 h after Dox-induced
I-Sce-I expressionSPOC1 localized to a large numberof foci
double-labeledbyGFP-LacR/53BP1 (Figure 1A,+I-Sce-I).
Determining the frequency of SPOC1 foci accumulation
at GFP-LacR/53BP1 double-labeled repair foci before
and 16 h after Dox-induced I-SceI-expression revealed an
increase from 8% to 40% (Figure 1B). Detailed analysis
of the recruitment kinetics showed rather late accumulation
of SPOC1 at these foci compared to 53BP1.
We also examined whether ATM kinase activity is
required for recruiting SPOC1 to I-SceI-induced DSBs.
Inhibition of ATM kinase almost completely reduced
SPOC1 recruitment to repair foci 16 h after Dox-induced
I-SceI expression (Figure 1D). Next, we examined whether
SPOC1 is present at large (2–3mm) 53BP1 containing
domains, also called OPT domains, which occur occasion-
ally inG1 cells (46,47). OPT domains are frequently located
at the periphery of nucleoli (48) and carry features of
DSBs in condensed chromatin regions (46,47). In fact, in
non-treated U2OS cells we observed a small number of
discrete 53BP1/SPOC1 positive foci that fulﬁll the criteria
of OPT domains (Figure 1E). Taken together, these data
demonstrate that SPOC1 is recruited to I-SceI-induced
DSBs in an ATM-dependent manner, as well as to OPT
domains that arise at sites of DNA damage.
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Furthermore, using the radiomimetic drug NCS we
could show that SPOC1 is recruited to DSBs induced
by the drug, although its accumulation at repair foci is
rather late compared to 53BP1 (Figure 2). These data
and the reported similar repair kinetics of g-IR- and
NCS-induced DSBs (30) provide evidence for SPOC1 ac-
cumulation at naturally occurring replication stress-,
I-SceI-, radiomimetic drug- and g-IR-induced repair foci
with slow repair kinetics, a well documented feature of
DSB repair in highly compacted chromatin regions (28).
The ﬁndings and the known function of SPOC1 in chro-
matin compaction/decondensation are consistent with
the assumption that SPOC1 contributes to structural
changes in chromatin required for repair of DSBs in
heterochromation.
SPOC1-expression levels inﬂuence the DDR after
c-irradiation
Wenext investigated the role of SPOC1 inDDRand repair,
and measured the effect of SPOC1 expression on the for-
mation of gH2AX and 53BP1 foci post-g-IR with 2Gy.
Expression of endogenous or exogenous FLAG-tagged
SPOC1 in CV1 cell lines was either diminished by speciﬁc
siRNA (Figure 3A) or induced by Dox (Figure 3B).
Thirtyminutes post-g-IR, the number of gH2AX and
53BP1 foci per cell counted in SPOC1-deﬁcient cells was
signiﬁcantly more than in control cells (Figure 3C and E).
At later time points during DNA repair, we detected little
difference between numbers of gH2AX and 53BP1 foci,
whereas the repair kinetics were faster (1.5-fold gH2AX
and 1.9-fold 53BP1) between 30min and 2 h, but not
between 8 and 24 h later (Figure 3C and E).
In contrast, SPOC1 overexpression signiﬁcantly reduced
the number of gH2AX, but not 53BP1 foci (Figure 3B, D
and F) 30min post-g-IR. Interestingly, the gH2AX and
53BP1 foci in SPOC1 overexpressing cells decreased, in
other words were repaired at a signiﬁcantly slower rate
(3.1-fold gH2AX and 2.7-fold 53BP1) between 30min
and 24 h post-g-IR compared to control cells (Figure 3D
and F). These ﬁndings suggest that increased SPOC1
expression interferes with the kinetics of IRIF formation/
disappearance and DNA repair.
Figure 1. SPOC1 is recruited to I-SceI-induced DSBs where it colocalizes with 53BP1. (A) In situ immunoﬂuorescence studies with U2OS19 ptight13
GFP-LacR cells with a stably integrated I-SceI cleavage site ﬂanked by lac operator repeats reveals localization of the GFP-lac repressor protein
(GFP-LacR) at the lac-operator DNA sequences in the nucleus before (I-SceI) and 16 h after I-SceI-induced (+ I-SceI) DSB. In contrast, SPOC1
(white) and 53BP1 (red) are distributed throughout the nucleus in the absence of I-Scel, and partially colocalized in naturally occurring repair foci.
After I-SceI cleavage to generate DSBs, SPOC1 and 53BP1 colocalize at distinct foci, including the cleaved DNA adjacent to DNA-bound
GFP-LacR. Proteins were visualized by immunostaining and confocal microscopy. Scale bars=10 mm. (B) Quantitative analysis of SPOC1 recruit-
ment to the 53BP1 and GFP-LacR positive lacO array before and 16 h after I-SceI induction. (C) Monitoring of the kinetics of SPOC1 and 53BP1
recruitment to DSBs between 0 and 24 h post-I-SceI induction. (D) Quantifying ATM kinase inhibitor-mediated effects on recruitment of SPOC1 and
53BP1 to DSBs as evident 16 h after I-SceI-induced cleavage. (E) SPOC1 and 53BP1 colocalize at a large discrete endogenous repair focus as
observed in some non-irradiated U2OS cells by immunostaining. Scale bar=10mm.
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To investigate whether the SPOC1 levels affect the extent
of inﬂicted DNA damage we performed Comet assays
using cells immediately after g-irradiation with 2Gy
kept on ice. Neither SPOC1 knockdown nor SPOC1
overexpression revealed signiﬁcant differences in the
initial number of DSB (Supplementary Figure S1A and
C). In the context of this experiment we also analyzed by
FACS whether altered SPOC1 levels are associated with
detectable changes in the cell cycle. We did not see
obvious differences between control cells, SPOC1-
depleted and SPOC1 overexpressing cells (Supplementary
Figure S1B and D). Taken together, up and down-
regulation of SPOC1 expression does not alter the
radiosensitivity of chromatin but inversely modulates the
kinetics of IRIF formation and DNA repair.
SPOC1 inversely affects NHEJ and HR activity
To evaluate which DNA DSB repair pathways SPOC1
inﬂuences we used the well-established H1299.EJ
(NHEJ) and H1299.GC (HR) reporter cell lines (39,41).
Both cell lines contain chromosomally integrated EGFP
that is only expressed after I-Scel-mediated cleavage and
repair (Supplementary Figure S2). By quantifying in vivo
EGFP expression, we observed 20% more NHEJ
activity after SPOC1 knockdown, but no change in HR
activity (Figure 4A and C). In contrast, SPOC1
overexpression in H1299.EJ cells decreased NHEJ
activity by 40% compared to control cells, as did a
SPOC1 N-terminal domain deletion (deltaN)
(Figure 4B). Interestingly, this inhibitory effect was not
observed with SPOC1 containing two critical amino acid
Figure 2. Comparative kinetics of 53BP1 and SPOC1 recruitment to radiomimetic drug NCS-induced DSBs. U2OS cells ﬁxed before (mock) or
at the indicated times post-treatment (+NCS), immunostained for SPOC1 (green) and 53BP1 (red) and analyzed by confocal microcopy. At
the earliest observation period after NCS treatment (15min) a large number of small 53BP1 stained DSB repair foci emerged, but were not detectably
stained by SPOC1. Between 2 to 24 h post-NCS treatment the number of small 53BP1 stained foci gradually, then almost completely disappeared,
concomitant with emerging larger repair foci. At around 8 h post-NCS treatment most of the large 53BP1-stained repair foci were also strongly
stained by SPOC1, suggesting SPOC1 is recruited to and accumulates at DSBs in heterochromatin known for their slow repair kinetics.
Scale bars=10mm.
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mutations in the H3K4me3-binding pocket (PHDmt). The
effect of SPOC1 on NHEJ is speciﬁc since EGFP-reporter
expression was not signiﬁcantly changed by transfection
of H1299.EJ cells with SPOC1-expression vectors or
siRNA (Supplementary Figure S3). These data indicate
that NHEJ DNA repair activity is modulated by SPOC1
in a dose- and PHD-dependent manner
In contrast, SPOC1 overexpression strongly suppressed
EGFP reporter expression in H1299.GC cells (unpub-
lished observations), making it impossible to evaluate
speciﬁc effects of SPOC1 overexpression on HR activity
in this system. Since we supposed that a SPOC1-mediated
effect on HR may be cell context dependent, we also
studied this in the well-established and frequently used
HR-reporter cell line U2OS DR-GFP (35). Compared to
the H1299.GC cell line, this reporter cell line differs in p53
status and the I-SceI chromosomal integration sites and its
associated chromatin structure. Using the U2OS DR-GFP
cell line we observed 60% less HR-mediated gene con-
version upon SPOC1-depletion. As a positive control we
induced siRNA-mediated depletion of CtIP, a protein
critical for the initial step of HR (49) (Figure 4D) and
observed that HR activity decreased by 90%. These
data and no apparent effect of SPOC1 depletion in the
H1299.GC cell line (Figure 4C) indicate a cell context-de-
pendent role of SPOC1 in HR. Combined with the
increase of NHEJ induced by SPOC1 knockdown as
observed in the NHEJ H1299.EJ reporter cell line, the
ﬁndings suggest that SPOC1 can shift the balance
between NHEJ and HR.
SPOC1 inﬂuences radiosensitivity after c-IR
To clarify the biological relevance of SPOC1-modulated
DDR and DSB repair, we analyzed the radiosensitivity of
CV1 cells lacking or overexpressing SPOC1 by clonogenic
survival assays. CV1 cells with reduced SPOC1 levels
formed more colonies than control cells after g-IR
(Figure 5A–C).
In contrast, CV1 cells stably overexpressing SPOC1
protein (clones in Figure 3B) formed fewer colonies after
g-IR (Figure 5D and E). Proliferation of non-irradiated
cells depleted for SPOC1 did not signiﬁcantly differ from
control cells, and was marginally slower in cells with
enhanced SPOC1 expression (Supplementary Figure S4).
Figure 3. SPOC1 dose-dependent modulation of DDR after g-IR. SPOC1 expression in CV1 cell lines was determined by immunoblotting cell
extracts with the indicated antibodies (Supplementary Information). (A) SPOC1 protein levels 72 h post-siRNA transfection; (B) Endogenous and
FLAG-SPOC1 expression in three stably transformed CV1 cell lines (clones #14, #17 and #23) pre- or 24 h post-Dox treatment. Signals were
quantiﬁed by densitometry. (C–F) IRIF visualized by indirect immunoﬂuorescence of CV1 cells (unpublished observations) were counted by auto-
mated imaging at various times after g-irradiation. (C, E) gH2AX and 53BP1 foci in CV1 cells 72 h after siRNA-mediated reduction of SPOC1
(siSPOC1) compared to control cells (siCtr). (D, F) gH2AX and 53BP1 IRIF in CV1 clone #14 before and after Dox-induced (24 h) expression of
FLAG-SPOC1. The IRIF of 700–1000 cells were counted in each of three independent radiation experiments and at different time points, and are
represented as the mean/cell±SEM. *P 0.05, **P 0.01, ***P 0.001.
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These data imply that SPOC1 modulates cellular
radiosensitivity.
SPOC1 modulates DDR and heterochromatin
building factors
SPOC1’s ability to alter chromatin compaction, DDR,
DNA repair and radiosensitivity could be linked. To
identify SPOC1 regulated factors with functions in more
than one of these processes, we explored SPOC1- and
g-IR-dependent changes in expression, subnuclear local-
ization and post-translational modiﬁcations of candidate
nuclear proteins. Cell extracts from control or SPOC1-
depleted CV1 cells either mock treated or g-irradiated
with 2Gy and collected 30min later were subfractionated
into soluble and chromatin-bound proteins and analyzed
by immunoblotting (Figure 6A). Upon g-IR of the
control cells SPOC1 protein levels decreased (2.1-fold)
in the soluble fraction and increased (1.3-fold) in the
Figure 4. SPOC1-expression levels modulate NHEJ activity. (A) siRNA-mediated SPOC1 depletion increases NHEJ activity in H1299.EJ reporter
cells compared to control siRNA-transfected cells as quantiﬁed by ﬂow cytometry detecting EGFP expression. NHEJ activity is only evident after
I-Scel-mediated cleavage in cells transfected with a plasmid expressing cytoplasmic SceI fused to glucocorticoid receptor ligand-binding domain
(SceI-GR), plus TA to translocate the fusion protein into the nucleus. (B) Enhanced expression of SPOC1wt and a SPOC1 N-terminal domain
deletion (deltaN), but not a PHD-deﬁcient derivative (PHDmt) strongly reduced NHEJ activity when analyzed and quantiﬁed as in (A). (C) DNA
repair activity by HR in H1299.GC reporter cells after SPOC1 siRNA or control siRNA transfection, quantiﬁed as in (A), were similar. (D)
HR-mediated DNA repair activity in U2OS-DR-GFP reporter cells was reduced by >60% after siRNA-induced SPOC1 knockdown compared
to control siRNA treated cells. Knockdown of CtIP, a protein critical for the initial steps of HR, reduced HR activity by 90% compared to the
control siRNA transfected cells. All data are from triplicates derived from three independent experiments (±SEM) ****P 0.0001. (A–D) Successful
SPOC1 and CtIP knockdown as well as equivalent expression levels of SPOC1 wt and mutant proteins were conﬁrmed by immunoblotting of cell
extracts using anti-SPOC1, anti-CtIP and anti-GAPDH antibodies.
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chromatin-rich fraction (Figure 6A, siCtr). Furthermore,
SPOC1 depletion appeared to increase phosphorylation-
dependent activation of ATM (pATM-S1981 (soluble
1.7-fold and chromatin-associated 1.9-fold), Chk2
(pChk2-T68, 3.6-fold) and gH2AX (1.6-fold) in irradiated
cells, whereas total levels of ATM and Chk2 remained
unchanged (Figure 6A). Increased pATM-S1891 and
pChk2-T68, phosphorylated by activated ATM (50,51),
after SPOC1-depletion indicates elevated DDR, and is
consistent with more IRIF, enhanced DNA repair kinetics
and increased NHEJ activity observed in the previous ex-
periments (Figures 3C, E, G and 4A).
ATM-mediated KAP-1 phosphorylation at serine 824
leads to chromatin decondensation, an important process
in DDR. Therefore, we evaluated whether SPOC1 affects
KAP-1 expression and phosphorylation, as well as that
of its binding partner HP1, which targets H3K9me3.
We detected 30% less chromatin-bound KAP-1 protein
in SPOC1-deﬁcient cells compared to controls cells
(Figure 6A). As expected, phosphorylated KAP-1 (pKAP-
1-S824) was only detected after g-IR, with levels related to
those of totalKAP-1 protein (Figure 6A). SPOC1 depletion
did not alter expression of any isoforms of HP1, although
levels of H3K9me3 were reduced (by 32% and 45% in non-
irradiated and irradiated cells, respectively) (Figure 6A).
Several H3K9 methylation enzymes (SETDB1, GLP,
G9A and SUV39H1) are present in large multisubunit
complexes that promote H3K9 trimethylation (33).
The amounts of three out of the four chromatin-
associated enzymes decreased upon SPOC1 depletion
both pre- and post-g-IR (Figure 6A) explaining the
decrease in H3K9me3. Less H3K9 KMTs, H3K9me3,
and chromatin-bound KAP-1 proteins are likely linked
to SPOC1 depletion-induced chromatin relaxation (2)
and probably enhance accessibility of damaged sites for
factors involved in DDR and repair.
Conversely, we tested whether SPOC1 overexpression
affects the same proteins. SPOC1 overexpression slightly
reduced both chromatin-bound ATM and activated ATM
(pATM-S1981) after g-IR (Figures 6B and Supplementary
Figure S5). The ATM-dependent phosphorylation of
KAP-1 at S824, as well as that of H2AX, was strongly
reduced in SPOC1 overexpressing cells (by 60% and 30%,
respectively), whereas total KAP-1 levels increased slightly
(1.7-fold, Figures 6B and Supplementary Figure S5A).
Reduced ATM activity is also in agreement with the
lower number of gH2AX foci and the globally reduced
gH2AX level observed after SPOC1 overexpression
(Figures 3D and 6B). These data argue that SPOC1 over-
expression impedes DDR and repair by promoting chro-
matin compaction.
To identify possible factors involved in SPOC1-induced
chromatin compaction that may also affect DDR, we
analyzed expression levels of the heterochromatin
markers HP1 (all isoforms), H3K9me3 and KAP-1.
Independent of g-IR, levels of HP1a, H3K9me3, and also
KAP-1 increased in the chromatin fraction 1.4-, 1.7- and
1.4-fold, respectively, after SPOC1 overexpression,
whereas those of HP1-b and HP1-g did not (Figure 6B, C
and Supplementary Figure S6). Elevated levels of HP1-a,
H3K9me3 and KAP-1 are consistent with the reported
ability of SPOC1 to induce chromatin compaction (2).
As above, we then evaluated expression levels of the
same H3K9 KMTs after SPOC1 overexpression. Now,
chromatin-bound levels of SETDB1, GLP and G9A, but
not SUV39H1, increased 1.2- to 1.4-fold in irradiated and
non-irradiated SPOC1-overexpressing cells (Figure 6B
and Supplementary Figure S5A). Thus, SPOC1 over-
expression increases chromatin-associated H3K9 KMT
and H3K9me3 levels, exactly the opposite of SPOC1
downregulation. Elevated H3K9me3 may promote chro-
matin compaction by recruiting appropriate epigenetic
readers and their binding partners, including HP1-a and
KAP-1, whereas lower H3K9me3 levels may have the
reverse effect. In summary, the observed SPOC1-
dependent changes in phosphorylation of ATM, Chk2
and KAP-1 could all contribute to SPOC1’s impact on
DDR and DNA repair.
SPOC1 interacts with KAP-1 and H3K9 KMTs
The observed correlation between chromatin-associated
KAP-1 and SPOC1 levels (Figure 6A and B) may be due
Figure 5. SPOC1 protein expression levels affect cell survival after
g-IR. (A) Immunoblot analysis shows that SPOC1 levels in SPOC1
siRNA transfected CV1 cells are reduced by 58% compared to
control siRNA-transfected cells as analyzed by densitometry. These
cells were used for clonogenic survival assays (see below). (B) Colony
formation assays: SPOC1-siRNA treated cells formed more colonies
than control siRNA transfected cells when analyzed after 8Gy g-IR
and 9 days post-plating, indicating higher radioresistence. (C) Survival
curves based on clonogenic growth of CV1 cells transfected with
SPOC1-siRNA or control siRNA, analyzed after 0–8Gy g-IR and up
to 9 days after plating. SPOC1 knockdown results in increased
radioresistance. (D) Colony formation assays: different SPOC1
overexpressing (1.7- to 5.4-fold) cell lines formed less colonies than
control cells when analyzed after 8Gy g-IR and 12 days post-plating,
indicating higher radiosensitivity. (E) Survival curves based on
clonogenic growth of SPOC1 overexpressing (1.7- to 5.4-fold) or
control cells after 0–8Gy g-IR and analyzed 12 days after plating.
SPOC1 overexpression results in lower radioresistance. Cells were
plated in two different densities and in triplicates. Mean values±SD
are given. *P 0.05; **P 0.01.
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to KAP-1 interacting with SPOC1. To provide direct
evidence for a SPOC1/KAP-1 interaction we performed
GST pull-down experiments (Figure 7A). Full-length
GST-SPOC1 protein precipitated KAP-1, unlike GST
alone or the N-terminal 100 amino acids of SPOC1
(GST-SPOC1 1-100; Figure 7A).
To independently verify, and further map the SPOC1/
KAP-1 interaction, we used a LUMIER-assay
(Figure 7B). Full-length or C-terminal SPOC1 fused to
protein A (ProtA-SPOC1; amino acids 1–300, 150–300)
pulled down luciferase (Luc) fused to full-length or
N-terminal KAP-1 (Luc-KAP-1; amino acids 1–835,
1–400), but not C-terminal derivatives (Luc-KAP-1;
amino acids 401–600, 601–835), while protein A-tagged
N-terminal KAP-1 (ProtA-KAP-1; amino acids 1–400) ef-
ﬁciently pulled down C-terminal SPOC1 (Luc-SPOC1;
amino acids 150–300) (Figure 7B). These results indicate
a speciﬁc interaction between the N-terminal 400 amino
acids of KAP-1 and the C-terminal 150 amino acids of
SPOC1. The interaction with SPOC1 may affect KAP-1
stability, phosphorylation, and/or its recruitment to chro-
matin before and after g-IR.
Figure 6. SPOC1 levels modify expression, modiﬁcation and localization of proteins involved in chromatin (de)compaction and DDR. Immunoblots
of soluble and chromatin-rich fractions from untreated () and irradiated cells collected 30min post-2Gy g-IR (+) analyzed with Abs against the
indicated proteins. (A) SPOC1-siRNA transfected cells show less SPOC1 protein than control CV1 cells. (B) Dox-treatment strongly enhances
SPOC1 levels in CV1 cell line clone #17. (A and B) Immunoblot signal intensities for different cellular proteins detected in the corresponding
cellular lysates show speciﬁc changes in expression of some but not all, depending on the soluble or chromatin fraction, SPOC1-expression levels and/
or g-IR. (C) Confocal immunoﬂuorescence analysis of mixed CV1 cells over and underexpressing SPOC1 immunostained for HP1-a (top), HP1-b
(middle) and HP1-g (lower panels) only showed enhanced HP1-a expression in SPOC1-overexpressing cells. SPOC1 was immunostained with
antibody CR56, the HP1 proteins with the antibodies given in ‘Materials and Methods’ section, and DNA was stained by DRAQ5. Scale
bars=5 mm.
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We then investigated whether SPOC1 interacts with
components of the H3K9 KMT multiprotein complex
(33,52). Endogenous SPOC1 from HeLa nuclear extracts
with anti-SPOC1 antibody but not with control antibody
coprecipitated both G9A and SETDB1 as revealed by im-
munoblotting (Figure 7C). In addition, both endogenous
SPOC1 and SETDB1 were speciﬁcally immunopre-
cipitated with antibodies against GLP or SUV39H1
(Figure 7D).
Previously described cell lines (52) expressing
either FLAG-tagged SETDB1 wt, or an enzymatically
inactive SETDB1 (SETDB1 H1224K), were used to
further evaluate the SPOC1/H3K9 KMT interaction.
With anti-FLAG antibodies wt SETDB1 efﬁciently
coprecipitated endogenous SPOC1 and all three tested
H3K9 KMTs (GLP, G9A and SUV39H1), compared to
the less efﬁcient coprecipitation by the mutant SETDB1
protein (Figure 7E). These data imply that SPOC1 inter-
action with H3K9 KMT molecular complexes partly
depends on SETDB1 enzymatic activity. The nuclear
extracts used for coimmunoprecipitation and protein
complex immunoafﬁnity puriﬁcation experiments were
pretreated with DNase with or without added RNase or
Etbr and analyzed for residual DNA by agarose gel elec-
trophoresis (see ‘Materials and Methods’ section and
Supplementary Figure S6). These experiments exclude
that coIPs of SPOC1 and H3K9 KMTs are mediated by
DNA.
An in vitro histone methlylation assay was then used
to check if SPOC1-bound H3K9 KMTs are enzymatically
active. The addition of chicken core histones and radio-
labeled Adenosy-L-Methionine-[methyl-3H] to SPOC1
immunoprecipitated proteins resulted in methylation
of histone H3, as also observed with immunoprecipitated
G9A or SETDB1 (Figure 7F). This result shows SPOC1-
bound H3K9 KMTs are active.
SPOC1 overexpression-induced increase of only chro-
matin-bound H3K9 KMT (Figure 6B) might depend on
SPOC1’s binding to chromatin. Therefore, we analyzed
H3K9me3 levels in total lysates from HeLa-S3 cell lines
expressing either endogenous or ectopically enhanced
levels of SETDB1, with or without lentivirally expressed
SPOC1 wt or the SPOC1-PHD mutant. Neither expres-
sion of SETDB1 nor SPOC1-PHD mutant alone increased
H3K9me3 levels (Figure 7G). In contrast, extra SPOC1 wt
signiﬁcantly enhanced H3K9me3 levels (Figure 7G), as
was seen in CV1 cells (Figure 6B). H3K9me3 levels
were even higher when both SPOC1 and SETDB1 were
overexpressed (Figure 7G). However, these coexpression
conditions did not detectably increase SETDB1
protein levels, suggesting instead that SPOC1 stimulates
SETDB1 activity. In summary, these data demonstrate
that SPOC1 overexpression can increase both chro-
matin-associated levels and activity of H3K9 KMTs,
thus enhancing H3K9 trimethylation.
DISCUSSION
Here, we provide the ﬁrst evidence that SPOC1-expression
levels have an impact on DDR, DNA repair kinetics and
pathway choice, as well as on cellular radiosensitivity. We
propose a molecular mechanism that is predominantly
deduced from the following observations: (i) ATM
kinase-dependent recruitment of SPOC1 to DSBs;
(ii) SPOC1 accumulation at endogenous and experimen-
tally induced repair foci with slow repair kinetics;
(iii) SPOC1-dependent differences in the number of
IRIFs formed early after g-IR; (iv) altered kinetics of
g-IR-inducible DSB repair; (v) altered cellular radio-
sensitivity; (vi) the ability of SPOC1 to modulate
dose-dependently both NHEJ and HR activity and (vii)
SPOC1’s interaction with, and modulation of proteins
that have intertwined functions in regulating chromatin
structure as well as DDR and DNA repair.
SPOC1 binding to chromatin and its PHD-dependent
ability to alter chromatin compaction (2), as well as its
predicted binding to H3K4me2/3 (3) were known; but
neither the underlying mechanisms nor the possible
impact of SPOC1-expression levels on DDR or DNA
repair have been described so far. We now propose an
integrative mechanistic model of SPOC1’s function in
altering chromatin structure, DDR and DNA repair
(Figure 8). Accordingly, by SPOC1 binding to chromatin
exposing H3K4me2/3, and/or different interaction
partners, chromatin can be compacted by SPOC1’s
ability to increase global or local levels of KAP-1,
HP1-a, H3K9 KMTs and H3K9me3. These heterochro-
matin building factors can act in concert or independently
in both gene repression and chromatin condensation
(17,53,54).
Loss of SPOC1 results in the release of several factors
and marks associated with chromatin condensation
(H3K9 KMTs, H3K9me3, KAP-1), and thus promotes
chromatin decondensation. SPOC1 dose-dependent chro-
matin condensation and decondensaton, previously shown
by micrococcal nuclease digestion experiments (2), is con-
sistent with this interpretation, and with the now
demonstrated associated differences in DDR, DNA
repair kinetics and cellular radiosensitivity. Moreover,
the ATM-dependent recruitment to and accumulation of
SPOC1 protein at heterochromatic repair foci and en-
dogenous 53BP1 bodies/OPT domains further argue for
SPOC1’s involvement in chromatin structural changes
required for timely repair and choice of repair pathways.
DSBs induced by low dose g-IR in chromatin condensed
locally and/or globally with the help of SPOC1 contribute
to impaired activation of ATM and delayed expansion of
gH2AX and 53BP1 at DSBs.
This interpretation is strongly supported by the
observed reduced levels of pKAP-1(S824), an essential
factor for decondensing and then repairing hetero-
chromatin-associated DSBs (28). In contrast, upon
SPOC1 depletion DSBs in decondensed chromatin are
associated with increased levels of DDR transducers
(pATM, gH2AX) and mediator 53BP1 involved in DNA
repair. Chromatin decondensation as well as increased
pATM are also consistent with the increased gH2AX
and 53BP1 accumulation at DSBs and their repair,
similar to that documented in human cells with deﬁcits
in other heterochromatin building factors (25). The
SPOC1-dependent positive and negative modulation of
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DNA repair results in decreased and increased cellular
radiosensitvity, which may be a consequence of SPOC1
also affecting the accuracy of DNA repair. The SPOC1
depletion-induced reduction in HR activity detected in the
p53 positive, but not p53 negative HR reporter cells could
be due in part, or entirely to the different p53 status.
This assumption is strongly supported by the recent
demonstration that DSB repair by HR is signiﬁcantly
compromised in the absence of DNA damage-induced
phosphorylation of p53 by the concerted action of
DNA-PK, ATM and ATR, as well as the well-docu-
mented effects of p53 on DNA repair mediated by its
functions in regulating the cell cycle and gene transcrip-
tion (55,56).
Figure 7. SPOC1 protein interacts with KAP-1 and enzymatically active H3K9 KMTs. (A) In GST-pulldown experiments with GST-SPOC1 wt,
GST-SPOC1 (amino acids 1–100) or GST alone and chromatin extracts from U2OS cells, only the GST-SPOC1-full-length protein precipitated the
KAP-1 protein, as detected on the immunoblot (lower panel). Amounts of GST proteins used were visualized by Amido black staining of the blots
(upper panel). Asterisks mark the positions of full-length GST-proteins. (B) LUMIER-assay for mapping the KAP-1/SPOC1 interaction. The
indicated combinations of SPOC1 and KAP-1, ProteinA (ProtA) and luciferase (Luc) fusion proteins were coexpressed. Luc activity coprecipitated
with IgG-beads was measured (Z-scores). Signiﬁcant KAP-1-interaction is only evident between both full-length proteins, or the C-terminal half of
SPOC1 and the N-terminal 400 amino acids of KAP1, as detected by signiﬁcant Luc activity in the corresponding pellets. Z-score 0.5 indicates an
interaction. Mean values±SD of three independent experiments each performed in triplicate are given. (C) Immunoprecipitation of SPOC1 from
HeLa nuclear extracts with anti-SPOC1 (lane 2) or with control antibodies (lane 1) and analysis of pelleted material by immunoblotting shows
speciﬁc coprecipitation of G9a and SETDB1 with SPOC1. (D) Immunoprecipitation (IP) of endogenous GLP or SUV39H1 from C2C12 cell extracts
and immunoblotting with the indicated Abs (IB Abs) against GLP (PP-B0422-00), SUV39H1 (07-550), SETDB1 (ab12317) and SPOC1 (6F6). Unlike
the control Ab, GLP and SUV39H1 Abs precipitated all associated KMTs as well as SPOC1. (E) Nuclear extracts of control C2C12 cells (lane 1) or
cells expressing HA-FLAG-tagged SETDB1 wt (lane 2) or SETDB1 H1224K mutant (lane 3) were analyzed on immunoblots (IB Ab.) with
antibodies against FLAG (F1804), G9A (D141-3), GLP (PP-B0422-00), SUV39H1 (07-550) and SPOC1 (6F6). After anti-FLAG-SETDB1
immunoprecipitation (IP) the immunoblot detected speciﬁc coprecipitation of SPOC1 by wt SETDB1 (lane 5) but much less by enzymatically
inactive SETDB1 H1224K (lane 6). (F) In vitro analysis of histone H3 methlylation by proteins immunoprecipitated by control, SPOC1, G9A,
or SETDB1 antibodies. Left panel: autoradiography and SimplyBlue staining of the assay products separated by SDS–PAGE. Right panel:
immunoblot which demonstrates that SPOC1, G9A and SETDB1 were immunoprecipitated speciﬁcally from the HeLa nuclear extracts. (G) In
total lysates from HeLa-S3 cell lines constitutively expressing HA-FLAG-SETDB1 (HA-SETDB1), lentiviral-mediated SPOC1wt expression elevates
H3K9me3 levels compared to control cells (REV), as detected by immunblotting with Abs against the indicated proteins (left). The SPOC1 PHD
mutant (SPOC1mut) unable to bind to H3K4me3 only marginally increased H3K9me3 levels compared to SPOC1 wt.
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A strong argument for SPOC1 playing a role in DDR
is the observed increase in chromatin-bound SPOC1
protein 30min after g-IR and a simultaneous decrease in
the nucleoplasmic fraction. This demonstrates that
nucleoplasmic SPOC1 responds to DNA damage early
on by its increased recruitment to chromatin. However,
unlike 53BP1 the SPOC1 protein did not detectably accu-
mulate at DSB repair foci, nor did the nuclear distribution
pattern visibly change 30min after g-IR. Therefore, we
assume that the pan-nuclear increase of chromatin-bound
SPOC1 represents an early response to DNA damage.
In contrast, ATM-dependent accumulation of SPOC1
was clearly observed at DSB-associated DNA repair foci
at 8 h post-DSB induction, with gradually increasing
SPOC1 and 53BP1 up to the end of the observation
period (24 h). By this late time period post-g-IR, the
number of foci had decreased and their size had grown
much larger, a feature characteristic of DSB repair
occurring in heterochromatic regions (25). These ﬁndings
are reminiscent of the distribution of pKAP-1(S824) post-
g-IR, which at early times is distributed in an pan-nuclear
manner and only detectably accumulates late in foci
formed at highly compacted chromatin (9).
Whether the DNA damage-induced changes in the
distribution pattern of chromatin-bound SPOC1 are also
mediated by ATM and/or Chk2 phosphorylation, as
reported for pKAP-1(S824/473), is an open question.
Alternatively, SPOC1 overexpression interfering with
KAP-1 at S824 phosphorylation may be caused by
KAP-1/SPOC1 protein–protein interaction-induced struc-
tural changes masking KAP-1 phosphorylation sites,
combined with, or independently of SPOC1-induced alter-
ation in ATM activity. SPOC1 may also affect KAP-1
dephosporylation, known to be mediated by phosphatase
PP4 (57,58). In addition, the SPOC1 overex-
pression-induced higher level of chromatin-bound HP1-a
may also affect KAP-1 phosphorylation, consistent with
HP1’s known regulatory roles in both KAP-1 phos-
phoryation and dynamic chromatin structural changes
occurring globally and locally at foci (59,60). Evidence
for HP1 proteins playing a role in the response to
g-IR-induced IRIFs and DDR (27,31,32,61) supports
our speculations. Whether SPOC1’s g-IR-induced chro-
matin-binding pattern is associated with, or driven by
changes in phosporylation or other post-translational
modiﬁcations on SPOC1, and/or by corecruited factors
involved in DDR is an interesting question that remains
to be examined.
The inverse correlation between SPOC1-expression
levels and the number of IRIF 30min post-2 Gy g-IR
raised the question of whether this reﬂects altered sensi-
tivity of DNA for DSB induction, subsequent DDR, or
repair. The Comet assay performed with cells deﬁcient in
or overexpressing SPOC1 showed no difference, indicating
Figure 8. Model: mechanisms of SPOC1-associated chromatin compaction and modulation of DDR at DSBs. The interaction of SPOC1 with
heterochromatin building factors KAP-1, HP1 and H3K9 KMTs and its binding to chromatin via H3K4me2/3 and/or other factors can induce
chromatin compaction. DNA damage-induced DSBs in heterochromatin activate ATM kinase. This results in pan-nuclear KAP-1S824 phosphor-
ylation and concomitant ATM recruitment to repair foci, and also to increasing accumulation at repair foci. SPOC1 is also ATM-dependently
recruited to DSBs and accumulates detectably only at heterochromatic repair foci after g-H2AX expansion and 53BP1 accumulation. The
KAP-1S824 phosphorylation required for chromatin relaxation at DSBs in heterochromatin and for DNA repair is regulated by SPOC1. For
more details see text.
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that SPOC1 does not alter the radiosensitivity of DNA.
This ﬁnding is consistent with increasing evidence for
similar sensitivity of euchromatin and heterochromatin
in forming DSBs (62,63). Therefore, we conclude that
SPOC1 modulates the kinetics of DNA repair foci forma-
tion and DNA repair, but not the extent of initial damage.
Since we failed to detect major changes in cell-cycle phase
regulation upon SPOC1 depletion or overexpression
(FACS analyses) and saw only minor changes in cell pro-
liferation, we believe that the SPOC1-dependent differ-
ences in cellular radiosensitivity are triggered by
SPOC1’s ability to differentially affect repair pathways,
and thus also the accuracy of DNA repair.
The chromatin compaction upon SPOC1 overex-
pression (2) and the observed changes in IRIF kinetics
are consistent with reports that DSBs in heterochromatin
become fully accessible for sensors and mediators of
DDR and repair only after partial chromatin relaxation
and translocation to the periphery of heterochromatin
(28,62,63). Proven or proposed key mediators of these
processes include ATM-mediated KAP-1 phosphorylation
(29), and epigenetic writers, readers and erasers
(6,9,19,23,28,60,64). We have shown here that several of
these mediators (KAP-1, HP1, ATM) are modulated by
SPOC1, possibly explaining at the molecular level the
observed SPOC1-mediated changes in the kinetics of
IRIF formation, DSB repair and radiosensitivity.
KAP-1 is one of the best studied heterochromatin
proteins and is phosphorylated in response to DNA
damage (17,29). It accumulates as pKAP-1-S824 and
mediates chromatin relaxation at IRIF in concert with
chromatin remodeler CHD3 (23), which is essential for
repairing DNA damage in heterochromatin. Our study
revealed SPOC1-dependent modulation of chromatin-
bound KAP1 in both g-irradiated and non-irradiated
cells. This change in KAP-1 levels may be due to
SPOC1/KAP-1 protein interaction-triggered (de)stabiliza-
tion, and presumably contributes to the SPOC1-
dependent changes in chromatin (de)condensation (2).
Although sequence analysis revealed no evident
KRAB-like domain, SPOC1 may act like KRAB contain-
ing proteins and other proteins shown to bind the RBCC
domain of KAP-1 (17). If true, some of the many thou-
sands of genes known to be targeted and transcriptionally
altered in vivo by KAP-1 (65,66) could be cotargeted and
regulated by SPOC1 in non-irradiated cells. However, the
considerable cell-type-speciﬁc differences in both KAP1
and SPOC1 expression, the discrepancies between
in vitro/in vivo data published for KAP-1-mediated recruit-
ment and gene regulation, as well as open questions con-
cerning the in vivo relevance of all KAP-1 protein
interactions with KRAB/KRAB-like proteins, except for
ZNF 274 (17), certainly make this a very demanding topic
to investigate.
All HP1 isoforms, HP1-a, HP1-b and HP1-g, are re-
cruited to DSBs in human cells independently of H3K9
trimethylation (6,31). Therefore HP1 proteins are appar-
ently important for DNA repair as well as their known
function in higher order chromatin structure, and may act
to stabilize loose ends and keep together sister chromatin
in response to damage. However, HP1 proteins also have
isoform-speciﬁc roles in DDR (6) and other biological
processes (67). For instance, human cells overexpressing
HP1-a and HP1-b, but not HP1-g, show increased sensi-
tivity to IR (68).
Our study corroborates this observation since
SPOC1 overexpression increased levels of HP1-a and
radiosensitivity. Whether the selective increase in HP1-a
expression is due to protein stabilization enhanced by
direct or indirect interaction with SPOC1 remains to be
studied. Independently of the regulatory mechanism,
increased HP1-a levels probably contribute to chromatin
compaction and impaired DDR. HP1-a overexpression
was recently reported in tumor tissues and proposed to
play a crucial role in cancer prognosis (69). The inverse
relationship of SPOC1-expression levels with cancer
patient survival time (1) may be related to SPOC1-
enhanced HP1-a expression.
The correlation between SPOC1 protein levels and
H3K9 trimethylation as well as expression of several
H3K9 KMTs implicates SPOC1 functions in both chro-
matin (de)condensation and DDR. H3K9me3 is not only
an epigenetic mark characteristic of heterochromatin, but
also the binding platform of HP1 and KAP-1, which col-
lectively promote heterochromatin compaction and
spreading (70,71).
Three lines of evidence indicate an important role for
H3K9me3 in DDR and DNA repair. First, a sharp
increase in H3K9me3 observed at I-SceI-induced DSBs
is thought to transiently silence the gene to ensure that
DNA repair is complete before transcription resumes,
and/or compact the chromatin to mute DNA damage sig-
naling stimulated by the initial chromatin opening (72).
Second, binding of the acetyltransferase TIP60 via its
CD to H3K9me3 at DSBs is required for its activation
(24), and is a prerequisite for efﬁcient ATM activation
by acetylation. Third, the level of heterochromatin-
associated histone modiﬁcation H3K9me3 can account
for >40% of mutation rate variation in human cancer
cells (5).
The increase in HP1-a in SPOC1 overexpressing cells
may interfere with TIP60 binding to H3K9me3 and its
activation, possibly contributing to the observed reduction
in activated ATM and delayed DDR. However, despite
reduced H3K9me3 levels in SPOC1-depleted cells, ATM
is apparently hyperactivated, perhaps indicating that its
activity is independent of H3K9me3. Possible reasons
for our observation are that ATM can also be activated
in cells with low H3K9me3 levels (24). Furthermore,
SPOC1 depletion, which promotes chromatin relaxation,
may increase accessibility of H3K9me3 for TIP60, leading
to increased ATM activation.
The histone H3K9 KMTs shown here to be modulated
by SPOC1 (SETDB1, G9A, GLP) exist in a multisubunit
complex that is destabilized by depleting the individual
components (33). While indirectly conﬁrming these
ﬁndings, our data also demonstrate the importance of
SPOC1’s interaction with this complex for its stability
and activity.
Evidence provided here on SPOC1’s impact on DDR,
DNA repair, and radiosensitivity may also be relevant for
the recently reported function of SPOC1 in testicular germ
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stem-cell differentiation. In particular, both SPOC1 (4)
and KAP-1 knockout (73) as well as a HP1-binding deﬁ-
cient KAP-1 mutant (74) all lead to progressive depletion
of spermatogonial stem cells and their differentiated
derivatives. The similar phenotypes of KAP-1 and
SPOC1 knockout in testis argues for a cooperative physio-
logical relationship in vivo in stem-cell maintenance and
differentiation.
The presumed function of SPOC1 in oncogenesis (1)
is consistent with its DDR modulating function shown
here. Moreover, since SPOC1 is able to alter cellular
radiosensitivity, it may be a relevant target for novel
anti-cancer drugs that focus on manipulating differences
in lysine methylation (75).
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